Septilin Plus

ЛП-001295

SEPTILIN® PLUS

International non-proprietary or generic name

Tablets

Each tablet contains:

microcrystalline cellulose 57.0 mg; crospovidone 43.0 mg; carmellose sodium 11.0 mg; colloidal silicon dioxide 5.0 mg; magnesium stearate 3.0 mg.

* The water is used as an extractant for the extract preparation from the collection of plant materials. Ratio (collection:dry extract - 5:1)

** The composition of the multicomponent herbal mixture Maharasnadi kwath includes: Terminalia chebula Retz. (Combretaceae); Terminalia bellerica L. (Combretaceae); Emblica officinalis Gaertn. (Euphorbiaceae); Fagonia cretica L. (Zygophyllaceae); Sida cordifolia L. (Malvaceae); Ricinus communis L. (Euphorbiaceae); Cedrus deodara (Roxb.ex Lamb.) G.Don (Pinaceae); Hedychium spicatum Ham.ex.Sm. (Zingiberaceae); Adhatoda vasica Nees. (Acanthaceae); Zingiber officinale Roscoe (Zingiberaceae); Piper chaba L. (Piperaceae); Cyperus rotundus L. (Cyperaceae); Boerhaavia diffusa L. (Nyctaginaceae); Tinospora cordifolia Miers. (Menispermaceae); Ipomoea digitata L. (Convolvulaceae); Anethum sowa Roxb. ex Flem. (Apiaceae); Tribulus terrestris L. (Zygophyllaceae); Withania somnifera L. Dunal. (Solanaceae); Cassia fistula L. (Fabaceae); Asparagus racemosus Willd. (Liliaceae); Piper longum L. (Piperaceae); Barleria prionitis L. (Acanthaceae); Coriandrum sativum L. (Apiaceae); Solanum xanthocarpum Schrad.et Wendl. (Solanaceae); Solanum indicum L. (Solanaceae).

Round biconvex uncoated tablets of greenish brown color interspersed with lighter and darker color spots.

Agent of plant origin.

SEPTILIN® PLUS has an anti-inflammatory effect. The active herbal substances (bioflavonoids and tannins) included in the agent help to reduce the inflammatory process manifestations, reduce capillary permeability, and exhibit an antiexudative action. The presence of polysaccharides in the agent promotes the stimulation of phagocytosis by increasing the phagocytic activity of granulocytes and macrophages, as well as by accelerating the chemotaxis of polymorphonuclear leukocytes in the infection focus. SEPTILIN® PLUS agent enhances the humoral immune response, promotes an increase in the nonspecific body resistance. The agent intake contributes to the relief of clinical signs of acute inflammation of the upper respiratory tract. The agent has an anti-inflammatory effect simultaneously on the mucous membrane of the nasopharynx, pharynx and palatine tonsils.

The data on the pharmacokinetics of the multicomponent agent of plant origin SEPTILIN® PLUS in the tablet pharmaceutical form are absent. The agent activity is stipulated by the mutually reinforcing combined action of its components, which is typical for the plant medicines. As far as it is impossible to designate the agent activity to any single compound in full, the pharmacokinetic studies of multicomponent agents of plant origin, including Cyston® tablets, are unrealizable.

Rhinosinusitis (acute, chronic exacerbation).

Exacerbation of chronic tonsillopharyngitis.

Hypersensitivity to the separate agent components. Age under 18.
Use with caution in patients with diseases of the gastrointestinal tract.

The agent intake during pregnancy and lactation period is contraindicated. If it is necessary to use the agent during lactation, the latter should be discontinued.

Peroral. 2 tablets BID for 10-14 days. In case of incomplete supression of disease symptoms, the treatment can be continued up to 4 weeks at a dose of 1 tablet BID or at the doctor's discretion.
In case of adverse events from the gastrointestinal tract the agent dose can be reduced to 1 tablet BID. If the dose reduction does not result in the symptom reduce, it is recommended to discontinue the agent.

The allergic reactions, a feeling of dry mouth, dyspeptic symptoms (nausea, diarrhea, flatulence), abdominal pain, a transient increase in the activity of "hepatic" transaminases are possible.
If you experience the side effects that are not described in this instruction, please, inform your doctor.

The information about the overdoses are absent. The treatment in case of overdose is symptomatic.

By the discontinuation of SEPTILIN® PLUS tablets the withdrawal effect was not observed. The special measures are not required when one or more doses are missed. In case the patient misses one or more doses, the agent should be continued according to the prescribed in the instruction regimen without doubling the dose.
No special precautions are required when disposing of unused medicine.

Tablets. 60 tablets in a high density polyethylene plastic vial with a screw cap. The vial neck is additionally tightened with aluminum foil applied by the company's trademark. Each vial with instructions for use is placed in a cardboard box.

In a dry place at a temperature of 15°C to 25°C.
Keep out of the reach of children.

3 years. Please do not use after the expiration date.

By prescription.